Circulating Tumour Cell Enumeration and Molecular Evaluation in Patients with Advanced Prostate Carcinoma.
Circulating Tumour Cell Enumeration and Molecular Evaluation in Patients with Advanced Prostate Carcinoma.
批准号:
G0601308/1
负责人:
Johann De Bono
金额:
$101.2万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --
中文摘要
前列腺癌是男性癌症死亡的第二大常见原因。自从睾丸睾酮剥夺被确定为一种治疗方式以来,这种疾病的治疗进展甚微。迫切需要加快开发针对这种疾病的新疗法。这种疾病治疗的主要瓶颈包括缺乏临床预测哪些药物会导致临床获益,以及缺乏获得激素抗性癌细胞以了解该疾病的生物学。这导致了长期的试验,持续多年,评估新的治疗方法是否延长了大量患者的死亡时间。预计,使用经过验证的新技术对患者血液中的前列腺癌细胞进行枚举、分离和研究,将加快临床试验,并允许获取肿瘤细胞以研究这种疾病的生物学,从而改善这一未满足需求的治疗方法。
英文摘要
Prostate cancer is the second commonest cause of death from cancer in men. Little progress has been made in the treatment of this disease since testicular testosterone deprivation was identified as a therapeutic modality. There is an urgent need to accelerate the development of novel therapies for this disease. Key bottlenecks to the treatment of this disease include poor clinical predictors of which drugs result in clinical benefit, and lack of access to hormone resistant cancer cells to understand the biology of the disease. This results in protracted trials, lasting many years, evaluating whether new treatments prolong time to death of large numbers of patients. It is envisioned that the enumeration, separation and study of prostate cancer cells in the blood of patients using validated new technology will expedite clinical trials and allow access to tumour cells for the study of the biology of this disease, leading to improvements in treatment for this unmet need.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating how Dysbiosis, Senescence and Inflammatory Storms Impact Prostate Carcinogenesis and Treatment Resistance to Transform Care.
-
批准号:MR/W018217/1
-
项目类别:Research Grant
-
资助金额:$265.72万
-
财政年份:2022
-
负责人:Johann De Bono
-
依托单位:
First clinical evaluation of a phosphoinositide 3-kinase (PI3K) inhibitor for the treatment of advanced prostate cancer.
-
批准号:G0502133/1
-
项目类别:Research Grant
-
资助金额:$58.72万
-
财政年份:2007
-
负责人:Johann De Bono
-
依托单位:
海外基金